EUVIMEDEUVIMED entdecken
Multizentrische StudieQuerschnittstudieOpen Access · CC BY 4.0

Financial difficulties experienced by patients with gastrointestinal stromal tumours (GIST) in the Netherlands: data from a cross-sectional multicentre study

Deborah van de Wal, Dide den Hollander, Ingrid M E Desar, Hans Gelderblom, Astrid W Oosten, Anna K L Reyners, Neeltje Steeghs, Olga Husson, Winette T A van der Graaf

Supportive Care in Cancer · 2024

DOI: 10.1007/s00520-024-08451-0 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Supportive Care in Cancer, 2024. Verfasst von Deborah van de Wal und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands. Hauptthemen laut MEDLINE: Gastrointestinal Stromal Tumors, Gastrointestinal Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study aims to (1) explore the prevalence of patient-reported financial difficulties among GIST patients, differentiating between those currently undergoing tyrosine kinase inhibitor (TKI) treatment and those who are not; (2) investigate associations between financial difficulties and sociodemographic and clinical characteristics, work, cancer-related concerns, anxiety and depression and (3) study the impact of financial difficulties on health-related quality of life.

Methods

A cross-sectional study was conducted among Dutch GIST patients diagnosed between 2008 and 2018, who were invited to complete a one-time survey between September 2020 and June 2021. Patients completed nine items of the EORTC item bank regarding financial difficulties, seven work-related questions, the Hospital Anxiety and Depression Scale, Cancer Worry Scale and EORTC QLQ-C30.

Results

In total, 328 GIST patients participated (response rate 63.0%), of which 110 (33.8%) were on TKI treatment. Patients currently treated with TKIs reported significantly more financial difficulties compared to patients not on TKIs (17.3% vs 8.7%, p = 0.03). The odds of experiencing financial difficulties was 18.9 (95% CI 1.7–214.7, p = 0.02) times higher in patients who were less able to work due to their GIST diagnosis. Patients who experienced financial difficulties had significantly lower global quality of life and functioning, and more frequently reported psychological symptoms as compared to patients who did not report financial difficulties.

Conclusion

Even in a country where the costs of TKIs and follow-up care are covered by health insurance, financial difficulties can be present in GIST patients, especially in patients on TKI treatment, and may negatively influence the quality of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal Stromal TumorsGastrointestinal NeoplasmsHumansCross-Sectional StudiesQuality of LifeNetherlandsProtein Kinase Inhibitors

Stichwörter der Autor:innen

Financial difficultiesFinancial toxicityGastrointestinal stromal tumourPatient-reported outcomeQuality of lifeTyrosine kinase inhibitors

Substanzen

Protein Kinase Inhibitors

Autor:innen und Institutionen

  • Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.
  • Department of Medical Oncology, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Department of Medical Oncology, Leiden University Medical Centre, Leiden, The Netherlands.
  • Department of Medical Oncology, Erasmus MC Cancer Institute, Erasmus University Medical Centre, Rotterdam, The Netherlands.
  • Department of Medical Oncology, University Medical Centre Groningen, University of Groningen, Groningen, The Netherlands.
  • Department of Clinical Pharmacology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.

Zitieren

APA

van de Wal, D., den Hollander, D., Desar, I. M. E., Gelderblom, H., Oosten, A. W., Reyners, A. K. L., Steeghs, N., Husson, O., & van der Graaf, W. T. A. (2024). Financial difficulties experienced by patients with gastrointestinal stromal tumours (GIST) in the Netherlands: data from a cross-sectional multicentre study. Supportive Care in Cancer. https://doi.org/10.1007/s00520-024-08451-0

Vancouver

van de Wal D, den Hollander D, Desar IME, Gelderblom H, Oosten AW, Reyners AKL, et al. Financial difficulties experienced by patients with gastrointestinal stromal tumours (GIST) in the Netherlands: data from a cross-sectional multicentre study. Supportive Care in Cancer. 2024. doi:10.1007/s00520-024-08451-0

BibTeX
@article{vandeWal2024,
  author = {van de Wal, Deborah and den Hollander, Dide and Desar, Ingrid M E and Gelderblom, Hans and Oosten, Astrid W and Reyners, Anna K L and Steeghs, Neeltje and Husson, Olga and van der Graaf, Winette T A},
  title = {Financial difficulties experienced by patients with gastrointestinal stromal tumours (GIST) in the Netherlands: data from a cross-sectional multicentre study},
  journal = {Supportive Care in Cancer},
  year = {2024},
  doi = {10.1007/s00520-024-08451-0}
}
Kostenlos starten →